Thalix
Thalidomide capsules for multiple myeloma and erythema nodosum leprosum. It influences the immune system and blood vessel growth.
- Category
- Oncology Support
- Active ingredient
- Thalidomide
- Route
- Oral use
- Form
- Capsule
- Strengths
- 50mg
Prescription and consultation requirements for Thalix vary by destination and are determined by the fulfilment partner.
Thalix details
- Conditions
- Multiple Myeloma · Erythema Nodosum Leprosum
- Alternative names
- thalidomide
- Therapeutic class
- Immunomodulatory Agent
- Pharmacological class
- Antineoplastic
- Contraindications
- pregnancy; hypersensitivity to thalidomide
- Minor side effects
- constipation; fatigue; headache
- Moderate side effects
- somnolence; peripheral neuropathy; dry skin
- Dosage forms
- Capsule
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Celgene
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Dexamethasone; Anticoagulants
- Age restrictions
- Approved for adults.
Serious side effects
phocomelia, requires immediate medical attention; deep vein thrombosis, requires immediate medical attention; severe peripheral neuropathy, requires immediate medical attention
Patient summary
Thalidomide capsules for multiple myeloma and erythema nodosum leprosum. It influences the immune system and blood vessel growth.
Mechanism of action
Inhibits basic TNF-alpha synthesis, blocks tumour cell division, and prevents angiogenesis within neoplastic structures.
Pregnancy and breastfeeding
Pregnancy: Highly teratogenic. Avoid any exposure. Use strict contraception protocols. Breastfeeding: Contraindicated.